Evangelia Tsolaki
Overview
Explore the profile of Evangelia Tsolaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
340
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsolaki E, Healy A, Ferguson S
Int J Pharm
. 2024 Nov;
667(Pt A):124878.
PMID: 39491654
Active Pharmaceutical Ingredient-Ionic liquids (API-ILs) have the potential to improve the bioavailability of BCS Class IV Drugs. However, the problematic physical handling properties of room temperature API-ILs have impaired clinical...
2.
Allawala A, Bijanki K, Adkinson J, Oswalt D, Tsolaki E, Mathew S, et al.
Oper Neurosurg (Hagerstown)
. 2024 Aug;
27(3):329-336.
PMID: 39145663
Background And Objectives: Recent advances in stereotactic and functional neurosurgery have brought forth the stereo-electroencephalography approach which allows deeper interrogation and characterization of the contributions of deep structures to neural...
3.
Remore L, Rifi Z, Tsolaki E, Ward M, Wei W, Tolossa M, et al.
Neurosurg Focus
. 2024 Jun;
56(6):E15.
PMID: 38823057
Objective: Essential tremor (ET) is the most common movement disorder. Deep brain stimulation (DBS) targeting the ventral intermediate nucleus (VIM) is known to improve symptoms in patients with medication-resistant ET....
4.
Tsolaki E, Kashanian A, Chiu K, Bari A, Pouratian N
Neuroimage Clin
. 2024 Feb;
41:103587.
PMID: 38422832
Objective: Deep brain stimulation (DBS) studies have shown that stimulation of the motor segment of the thalamus based on probabilistic tractography is predictive of improvement in essential tremor (ET). However,...
5.
Remore L, Tolossa M, Wei W, Karnib M, Tsolaki E, Rifi Z, et al.
Neuromodulation
. 2023 Apr;
27(4):690-700.
PMID: 37115122
Objective: Major depression affects millions of people worldwide and has important social and economic consequences. Since up to 30% of patients do not respond to several lines of antidepressive drugs,...
6.
Stocker M, Tsolaki E, Harding M, Healy A, Ferguson S
J Pharm Sci
. 2023 Feb;
112(8):2079-2086.
PMID: 36806585
The addition of non-active components at the point of active pharmaceutical ingredient (API) isolation by means of co-processing is an attractive approach for improving the material properties of APIs. Simultaneously,...
7.
Remore L, Omidbeigi M, Tsolaki E, Bari A
Seizure
. 2023 Jan;
105:22-28.
PMID: 36657225
Deep brain stimulation (DBS) of the thalamic nuclei for the treatment of drug-resistant epilepsy (DRE) has been investigated for decades. In recent years, DBS targeting the anterior nucleus of the...
8.
Malekmohammadi M, Mustakos R, Sheth S, Pouratian N, McIntyre C, Bijanki K, et al.
J Neural Eng
. 2022 Jul;
19(4).
PMID: 35790135
Therapeutic efficacy of deep brain stimulation (DBS) in both established and emerging indications, is highly dependent on accurate lead placement and optimized clinical programming. The latter relies on clinicians' experience...
9.
Kashanian A, Tsolaki E, Caruso J, Bari A, Pouratian N
Neurosurg Clin N Am
. 2022 Jun;
33(3):345-350.
PMID: 35718405
In recent years, the hunt for objective biomarkers in chronic pain has intensified, as interest has grown in precision medicine techniques, and the global opioid crisis has underscored the need...
10.
Tadayonnejad R, Majid D, Tsolaki E, Rane R, Wang H, Moody T, et al.
Front Psychiatry
. 2022 Mar;
13:806327.
PMID: 35321230
Diminished motivation to pursue and obtain primary and secondary rewards has been demonstrated in anorexia nervosa (AN). However, the neurobehavioral mechanisms underlying the behavioral activation component of aberrant reward motivation...